TFC Financial Management’s Biogen BIIB Stock Holding History

TFC Financial Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$734	Hold	4	–	–	﹤0.01%	650
2025 Q4	$704	Hold	4	–	–	﹤0.01%	646
2025 Q3	$561	Buy	4 +3	+300%	+$406	﹤0.01%	700
2025 Q2	$126	Buy	+1	New	+$125	﹤0.01%	845
2025 Q1	–	Sell	-3	Closed	-$459	–	970
2024 Q4	$459	Hold	3	–	–	﹤0.01%	669
2024 Q3	$582	Sell	3 -4	-57%	-$837	﹤0.01%	645
2024 Q2	$1.62K	Buy	7 +3	+75%	+$652	﹤0.01%	510
2024 Q1	$863	Buy	4 +1	+33%	+$234	﹤0.01%	569
2023 Q4	$777	Sell	3 -3	-50%	-$737	﹤0.01%	546
2023 Q3	$1.54K	Hold	6	–	–	﹤0.01%	492
2023 Q2	$1.71K	Hold	6	–	–	﹤0.01%	459
2023 Q1	$1.67K	Buy	6 +3	+100%	+$830	﹤0.01%	472
2022 Q4	$831	Hold	3	–	–	﹤0.01%	474
2022 Q3	$1K	Buy	+3	New	+$637	﹤0.01%	445
2021 Q2	–	Sell	-246	Closed	-$69K	–	577
2021 Q1	$69K	Hold	246	–	–	0.03%	167
2020 Q4	$60K	Sell	246 -4	-2%	-$1.03K	0.03%	177
2020 Q3	$71K	Buy	+250	New	+$69.7K	0.04%	149

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TFC Financial Management's BIIB Position: Q1 2026 in Review

TFC Financial Management held its Biogen (BIIB) position steady in Q1 2026 at 4 shares worth $734. The position accounts for ﹤0.01% of the portfolio, ranked #650.

TFC Financial Management first reported a position in BIIB in Q3 2020 and has held it in 17 quarters since. The position peaked at $71K in Q3 2020. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

TFC Financial Management held 4 shares of Biogen worth $734 as of Q1 2026.
TFC Financial Management left its Biogen share count unchanged in Q1 2026.
Biogen made up ﹤0.01% of TFC Financial Management's portfolio in Q1 2026, its #650 holding.
TFC Financial Management first reported a position in Biogen in Q3 2020 and has held it in 17 quarters since.
TFC Financial Management's Biogen position peaked at $71K in Q3 2020.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on TFC Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.